Viatris Inc recalls Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles
Recalled December 18, 2024 · FDA recall D-0127-2025 · Viatris
Hazard
Superpotent Drug and Subpotent Drug: potency failures obtained · FDA Class II
Units
65,169
Sold at
Nationwide within the United States and Puerto Rico
Description
Superpotent Drug and Subpotent Drug: potency failures obtained
Product
Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-count bottles (NDC 0378-1809-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.
Manufacturer(s)
Viatris Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →